Company / Current Assets
REGENXBIO Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$281.3M
FY2025
5-year range
$278.0M / $518.8M
FY2021-FY2025
Trend
+1.2%
vs FY2024
Sector context
#171 of 213
Health Care
What the data says
REGENXBIO Inc.'s current assets of $281M is lower than 80% of companies in the Health Care sector (FY2025). Current Assets returned to growth in FY2025 after 4 years of decline, reaching $281M.
Based on SEC 10-K filings.
$281M in FY2025 with a 5-year CAGR of -11.9%.
Declined from $335M to $281M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -12.2%
- 5-Year CAGR
- -11.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 213This company $281.3M Sector average $2.5B
▼
-88.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -11.9%, indicating a declining trend.
- In FY2025, current assets increased 1.2% year-over-year.
- Ranks #171 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $281.3M | +1.2% |
| FY2024 | $278.0M | -17.0% |
| FY2023 | $335.0M | -19.5% |
| FY2022 | $416.0M | -19.8% |
| FY2021 | $518.8M | -2.3% |
| FY2020 | $531.2M | +54.0% |
| FY2019 | $345.0M | +2.1% |
| FY2018 | $337.9M | +101.1% |
| FY2017 | $168.0M | +79.9% |
| FY2016 | $93.4M | -21.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026